The groundbreaking success of the copyright undeniably reshaped the medication landscape, but investing in companies strongly reliant on generic versions presents a uncertain picture. Although early profits were impressive, the end of patents and the emergence of discounted alternatives have diminished market share. Therefore, a thorough evaluat… Read More